Bank of America’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-57
Closed -$649 6035
2025
Q4
$649 Buy
57
+31
+119% +$409 ﹤0.01% 6524
2025
Q3
$451 Sell
26
-1
-4% -$11 ﹤0.01% 7607
2025
Q2
$358 Sell
27
-720
-96% -$9.99K ﹤0.01% 7725
2025
Q1
$9.14K Hold
747
﹤0.01% 7130
2024
Q4
$11.7K Sell
747
-3
-0.4% -$52 ﹤0.01% 6943
2024
Q3
$16.8K Buy
750
+3
+0.4% +$61 ﹤0.01% 6782
2024
Q2
$17.8K Sell
747
-175
-19% -$4.96K ﹤0.01% 6766
2024
Q1
$28.2K Sell
922
-329
-26% -$12.5K ﹤0.01% 6681
2023
Q4
$43K Sell
1,251
-196
-14% -$6.98K ﹤0.01% 6644
2023
Q3
$94.9K Sell
1,447
-102
-7% -$6.87K ﹤0.01% 6270
2023
Q2
$124K Buy
1,549
+188
+14% +$14.3K ﹤0.01% 6107
2023
Q1
$112K Buy
1,361
+797
+141% +$78.3K ﹤0.01% 6213
2022
Q4
$48.3K Hold
564
﹤0.01% 6484
2022
Q3
$52K Sell
564
-1,544
-73% -$166K ﹤0.01% 6655
2022
Q2
$259K Buy
2,108
+484
+30% +$56.8K ﹤0.01% 5911
2022
Q1
$190K Sell
1,624
-195
-11% -$32.3K ﹤0.01% 6498
2021
Q4
$472K Buy
1,819
+1,182
+186% +$359K ﹤0.01% 5917
2021
Q3
$174K Buy
637
+9
+1% +$2.6K ﹤0.01% 6396
2021
Q2
$268K Buy
628
+477
+316% +$182K ﹤0.01% 5873
2021
Q1
$58K Buy
+151
New +$68K ﹤0.01% 6589
2020
Q4
Sell
-85
Closed -$21.9K 7144
2020
Q3
$29K Buy
+85
New +$23K ﹤0.01% 6200
2020
Q2
Hold
0
6886
2020
Q1
Hold
0
6922
2019
Q4
Sell
-15
Closed -$1.66K 7142
2019
Q3
$2K Buy
15
+12
+400% +$2.08K ﹤0.01% 6988
2019
Q2
$1K Buy
+3
New +$778 ﹤0.01% 7019
2019
Q1
Hold
0
7167
2018
Q4
Hold
0
7162
2018
Q3
Hold
0
7301
2018
Q2
Hold
0
7120
2018
Q1
Hold
0
7140
2017
Q4
Hold
0
7059
2017
Q3
Hold
0
7088
2017
Q2
Hold
0
6981
2017
Q1
Hold
0
7014
2016
Q4
Hold
0
7096
2016
Q3
Sell
-4
Closed -$9K 7151
2016
Q2
$9K Buy
+4
New +$8.17K ﹤0.01% 6524
2016
Q1
Hold
0
6857

Other funds holding DRIO

Bank of America's DRIO Position: Q1 2026 in Review

Bank of America sold out of DarioHealth (DRIO) in Q1 2026, closing a stake of 57 shares — an estimated $649 sold.

Bank of America first reported a position in DRIO in Q2 2016 and held it in 24 quarters. The position peaked at $472K in Q4 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.

  • Bank of America reported no remaining DarioHealth position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 57 DarioHealth shares in Q1 2026, an estimated $649.
  • Bank of America first reported a position in DarioHealth in Q2 2016 and held it in 24 quarters.
  • Bank of America's DarioHealth position peaked at $472K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.